查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1616728

微導管市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Microcatheters Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球微導管市場價值為 9.855 億美元，預計 2024 年至 2032 年複合年成長率為 5.1%。 這種成長主要是由微創外科手術需求的成長和導管技術進步推動的。微創外科手術的激增是市場擴張的主要催化劑。這些手術因其相對於傳統開放性手術的優勢而受到關注，例如恢復時間更快、併發症風險更低、疼痛和疤痕更少以及住院時間更短。因此，神經病學、心臟病學、腫瘤學和周邊血管治療等不同醫學領域明顯轉向微創手術 (MIS)。

該行業分為產品、設計、應用、最終用途和地區。該市場將產品細分為輸送微導管、診斷微導管、抽吸微導管和可操縱微導管。值得注意的是，可操縱領域預計將成長最快，複合年成長率為 5.3%。這種激增歸因於它們在心血管血管造影中的使用不斷增加，與標準微導管相比，它們的成功率更高，手術時間更短。

其獨特的功能允許即時角度調整，提高超選擇性血管插管的效率。微導管的應用涵蓋心血管、神經血管、周邊血管、腫瘤學等。心血管領域在市場中佔據主導地位，2023 年銷售額約為 4.012 億美元。世界衛生組織 (WHO) 強調了這個問題的嚴重性，指出 CVD 是全球頭號死因，佔所有死亡人數的 30% 以上。這一強勁數字是由神經血管和心血管疾病盛行率上升以及經皮冠狀動脈介入手術的增加所推動的。此外，政府措施、成熟的醫療設施網路以及先進技術產品的現成也推動了這一成長。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 9.855 億美元
預測值 16 億美元
複合年成長率 5.1%

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 微創外科手術數量不斷增加
      • 慢性病患者數量不斷增加
      • 技術進步
    • 產業陷阱與挑戰
      • 與微導管相關的高風險和複雜性
  • 成長潛力分析
  • 監管場景
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢
  • 報銷場景
  • 差距分析
  • 2023 年定價分析
  • 價值鏈分析
  • 生態系測繪

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

  • 主要趨勢
  • 輸送微導管
  • 診斷微導管
  • 抽吸微導管
  • 可操縱微導管

第 6 章：市場估計與預測：按設計，2021 - 2032

  • 主要趨勢
  • 單腔微導管
  • 雙腔微導管

第 7 章：市場估計與預測：按應用分類，2021 - 2032

  • 主要趨勢
  • 心血管
  • 神經血管
  • 周圍血管
  • 腫瘤學
  • 其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 門診手術中心

第 9 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Acrostak
  • Asahi Intecc USA, Inc.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc (Abbott Laboratories, Inc.)
  • Cook Medical
  • Embolx, Inc.
  • Integer Holdings Corporation
  • Medtronic plc
  • Merit Medical System, Inc.
  • Penumbra, Inc.
  • Reflow Medical, Inc.
  • Stryker Corporation
  • Teleflex Corporation
  • Terumo Corporation
  • Transit Scientific
簡介目錄
Product Code: 3572

The Global Microcatheters Market was valued at USD 985.5 million in 2023 and is projected to grow at a CAGR of 5.1% from 2024 to 2032. This growth is largely fueled by rising demand for minimally invasive surgical procedures and technological advancements in catheters. The surge in minimally invasive surgical procedures is a primary catalyst for the market expansion. These surgeries have gained traction due to their advantages over traditional open surgeries, such as quicker recovery times, reduced complication risks, less pain and scarring, and shorter hospital stays. Consequently, there has been a pronounced shift towards minimally invasive surgeries (MIS) across diverse medical fields, including neurology, cardiology, oncology, and peripheral vascular treatments.

The industry is divided into product, design, application, end-use, and region. The market segments products into delivery microcatheters, diagnostic microcatheters, aspiration microcatheters, and steerable microcatheters. Notably, the steerable segment is projected to grow the fastest, at a 5.3% CAGR. This surge is attributed to their rising use in cardiovascular angiography, where they offer enhanced success rates and shorter procedural times compared to standard microcatheters.

Their unique feature allows real-time angulation adjustments, boosting the efficiency of super-selective vessel cannulation. Applications of microcatheters span cardiovascular, neurovascular, peripheral vascular, oncology, and more. The cardiovascular segment dominated the market, raking in approximately USD 401.2 million in 2023. This prominence is largely due to the escalating global incidence of cardiovascular disorders (CVDs). The World Health Organization (WHO) highlights the gravity, noting CVDs as the top global death cause, accounting for over 30% of all deaths.In 2023, North America generated a substantial USD 331.4 million in microcatheter revenue. This robust figure is driven by a rising prevalence of neurovascular and cardiovascular diseases and an uptick in percutaneous coronary intervention procedures. Furthermore, bolstering this growth are government initiatives, a network of established healthcare facilities, and the ready availability of advanced technological products.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$985.5 Million
Forecast Value$1.6 Billion
CAGR5.1%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing number of minimally invasive surgical procedures
      • 3.2.1.2 Increasing number of patients suffering from chronic diseases
      • 3.2.1.3 Technological advancements
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High risk and complexity associated with microcatheters
  • 3.3 Growth potential analysis
  • 3.4 Regulatory scenario
  • 3.5 Technology landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Future market trends
  • 3.9 Reimbursement scenario
  • 3.10 Gap analysis
  • 3.11 Pricing analysis, 2023
  • 3.12 Value chain analysis
  • 3.13 Ecosystem mapping

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Delivery microcatheter
  • 5.3 Diagnostic microcatheter
  • 5.4 Aspiration microcatheter
  • 5.5 Steerable microcatheter

Chapter 6 Market Estimates and Forecast, By Design, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Single lumen microcatheter
  • 6.3 Dual lumen microcatheter

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cardiovascular
  • 7.3 Neurovascular
  • 7.4 Peripheral vascular
  • 7.5 Oncology
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Acrostak
  • 10.2 Asahi Intecc USA, Inc.
  • 10.3 Boston Scientific Corporation
  • 10.4 Cardiovascular Systems, Inc (Abbott Laboratories, Inc.)
  • 10.5 Cook Medical
  • 10.6 Embolx, Inc.
  • 10.7 Integer Holdings Corporation
  • 10.8 Medtronic plc
  • 10.9 Merit Medical System, Inc.
  • 10.10 Penumbra, Inc.
  • 10.11 Reflow Medical, Inc.
  • 10.12 Stryker Corporation
  • 10.13 Teleflex Corporation
  • 10.14 Terumo Corporation
  • 10.15 Transit Scientific